The filing for securities offerings indicates that Ambrx Biopharma is seeking to raise capital, which could be used for various purposes such as funding research and development, paying off debt, or financing acquisitions. This could potentially impact the company's stock price, depending on how investors perceive the news and the company's intended use of the funds.